Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Triclabendazole (CGA89317) has been used in trials studying Parasitic Disease.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 10,000 | |||
50 mg | 在庫あり | ¥ 14,500 | |||
100 mg | 在庫あり | ¥ 18,500 | |||
200 mg | 在庫あり | ¥ 23,500 | |||
500 mg | 在庫あり | ¥ 38,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | Triclabendazole (CGA89317) has been used in trials studying Parasitic Disease. |
In vitro | Triclabendazole treatment produces percentage decreases of the fluke egg output by 15.3%, 4.3% and 36.6%, respectively, in sheep, dairy cows and heifers, these results indicate the presence of TCBZ-resistant Fasciola hepatica in sheep and cattle on this farm. [1] Triclabendazole sulphoxide (50 mg/mL) results in extensive damage to the tegument of triclabendazole-susceptible F. hepatica, whereas triclabendazole-resistant flukes shows only localized and relatively minor disruption of the tegument covering the spines. [2] |
別名 | CGA89317 |
分子量 | 359.66 |
分子式 | C14H9Cl3N2OS |
CAS No. | 68786-66-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 67 mg/mL (186.3 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Triclabendazole 68786-66-3 Cytoskeletal Signaling Microbiology/Virology Parasite Microtubule Associated Inhibitor CGA-89317 Microtubule/Tubulin CGA 89317 inhibit CGA89317 inhibitor